ANCORA INNOVATION
Ancora Innovation is a partnership that brings together Vanderbilt's innovative life science discovery efforts and Deerfield's commitment to accelerating state-of-the-art drug development. Deerfield will provide up to $65 million in funding to Ancora Innovation to pursue novel therapeutics, as well as additional capital to successful start-up companies spun out of Ancora.
ANCORA INNOVATION
Industry:
Product Research Therapeutics
Founded:
2018-03-06
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.ancorainnovation.com
Total Employee:
1+
Status:
Active
Total Funding:
65 M USD
Technology used in webpage:
Amazon Caldera Forms
Similar Organizations
Cabaletta Bio
Cabaletta Bio has adapted clinically-validated and FDA-approved CAR T cell technology to target B cell-mediated autoimmune diseases.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Investors List
Deerfield
Deerfield investment in Venture Round - Ancora Innovation
Official Site Inspections
http://www.ancorainnovation.com
- Host name: server-3-167-88-28.iad55.r.cloudfront.net
- IP address: 3.167.88.28
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
